A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

More than 40,000 people in the United States are living with cystic fibrosis, a genetic disease that affects the mucous ...

A significant number of people had asymptomatic liver disease, according to a large-scale European study. The LIVERSCREEN study is assessing a feasible, non-invasive screening strategy for liver ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...

This is the summary of "Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective," published ...

A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works ...

May is Cystic Fibrosis Awareness Month - learn about this genetic condition causing thick mucus and organ damage.